top of page

MENU

  • AutorenbildJuergen Mairhofer

Improved gene expression in E. coli

enGenes Biotech has developed customizable and scalable solutions for the production of recombinant proteins in microbial expression systems.

Its world-leading enGenes-eXpress technology delivers outstanding gene expression in Escherichia coli (E.coli). This platform technology for growth-decoupled protein production allows enGenes to develop economic, scalable and efficient production processes within short time frames to make clients’ unique products into commercial successes.

Cost-effective prokaryotic protein expression

enGenes combines in-depth experience in cutting-edge genetic engineering with a broad expertise in bioprocess engineering to deliver best-in-class microbial protein expression systems. Based on a strong understanding for the requirements of the biotech industry and extensive knowledge and method portfolio, enGenes delivers improved host cell lines, plasmid expression vectors and optimized production processes to maximize bio-process efficacy.

Its customized project plans and feasibility studies also responds to individual documentation requirements to support an easy transfer to clients’ own facilities and quality management systems. enGenes was founded by internationally recognized scientists in the field of microbial-based protein expression with an extensive track-record of scientific publications, patents and a strong understanding for the requirements of the biotech industry from a long history of international cooperation.

Comments


bottom of page